Long-term Safety of Satralizumab in Neuromyelitis Optica Spectrum Disorder (NMOSD): Results from the Phase 3 SAkuraSky and SAkuraStar Studies (S25.010)
Neurology | December 6, 2023 | Volume: 98 | Issue: 18_supplement | Pages: No page available
10.1212/wnl.98.18_supplement.1354